Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects

NCT02322671 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Disorders

Interventions

DRUG: Reference Montelukast
DRUG: Test 1 Montelukast
DRUG: Test 2 Montelukast

Sponsor

GlaxoSmithKline